Rufinamide
Overview
Rufinamide is an anticonvulsant medication used in the treatment of Lennox-Gastaut syndrome, a severe form of childhood epilepsy. It works by preventing the repetitive firing of sodium-dependent action potentials in brain cells.
API suppliers (9)
Suppliers of Rufinamide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 7 of 9 suppliers.
6 of 9 hold a GMP certificate on record in the EU or UK registers
- Micro Labs Usa1 active DMF
- Dipharma Francis SrlItaly1 active DMF GMP on record
- ALIVUS LIFE SCIENCES LTDIndia1 active DMF GMP on record
- LUPIN MANUFACTURING SOLUTIONS LTD1 active DMF
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- Hetero Drugs LimitedIndia1 active DMF GMP on record
- Apotex Inc.Canada1 active DMF
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
- Zhejiang Jiuzhou Pharmaceutical Co., Ltd.China GMP on record
Therapeutic areas
Do you supply Rufinamide? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.